Ulcerative Colitis

Please read these Terms of Use and Privacy Statement (collectively, the "Terms") carefully before using any of the box above indicates that you accept these Terms.

Ulcerative Colitis

Are you interested in exploring ongoing clinical trials for Ulcerative Colitis at the University of Alabama at Birmingham?


Following specialists treat  Ulcerative Colitis. Help us improve our data based on your experience.

Based on your feedback, we will add the specialty within 1 month










Specialty scores for Ulcerative Colitis


Ulcerative colitis (UC) is a disease that causes inflammation and sores, called ulcers, in the lining of the rectum and colon. It is one of a group of diseases called inflammatory bowel disease.

UC can happen at any age, but it usually starts between the ages of 15 and 30. It tends to run in families. The most common symptoms are pain in the abdomen and blood or pus in diarrhea. Other symptoms may include

  • Anemia
  • Severe tiredness
  • Weight loss
  • Loss of appetite
  • Bleeding from the rectum
  • Sores on the skin
  • Joint pain
  • Growth failure in children

About half of people with UC have mild symptoms.

Doctors use blood tests, stool tests, colonoscopy or sigmoidoscopy, and imaging tests to diagnose UC. Several types of drugs can help control it. Some people have long periods of remission, when they are free of symptoms. In severe cases, doctors must remove the colon.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

FDA Approved Medicines

  • FDA approved balsalazide disodium, sold as Colazal, manufactured by Salix Pharmaceuticals as mild to moderately active ulcerative colitis ( Ulcerative Colitis ) in year 2000.
  • FDA approved mesalamine, sold as Asacol, manufactured by Procter & Gamble for the treatment of ulcerative colitis ( Ulcerative Colitis ) in year 1997.
  • FDA approved mesalamine, sold as Canasa, manufactured by Axcan for the treatment of active ulcerative proctitis ( Proctitis | Ulcerative Colitis ) in year 2001.
  • FDA approved vedolizumab, sold as Entyvio, manufactured by Millenium Pharmaceuticals for the treatment of adults with ulcerative colitis and Crohn's disease ( Crohn Disease | Ulcerative Colitis ) in year 2014.
  • FDA approved budesonide, sold as Uceris, manufactured by Santarus for the treatment of ulcerative colitis ( Ulcerative Colitis ) in year 2013.